Trimetazidine for diabetic nerve pain
This trial tests whether the drug trimetazidine can improve nerve damage symptoms in people with type 2 diabetes and diabetic neuropathy. It also looks at how the drug affects a substance in the blood called endothelin-1, which may be involved in nerve damage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have type 2 diabetes.
- You have diabetic neuropathy.
- Your HbA1c (average blood sugar) is above 7%.
- You do not have any of the exclusion conditions listed (e.g., autoimmune disorders, serious organ disease, recent infection, pregnancy).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether melatonin can help relieve pain and discomfort from diabetic peripheral neuropathy (nerve damage caused by diabetes). If you have type 2 diabetes with nerve pain and are on stable diabetes medications, you may be eligible.
This study tests a new medicine called tirzepatide to see if it can improve nerve damage in the feet and legs caused by diabetes. It may be a good option for people with diabetes who also struggle with weight.
This study tests whether piracetam can help relieve nerve pain caused by diabetes (peripheral neuropathy). It's for people with type 2 diabetes who use insulin and have high blood sugar levels.
This trial tests an experimental medicine called suzetrigine to see if it can safely reduce pain caused by nerve damage from diabetes (diabetic peripheral neuropathy). It might be an option if you have had daily pain in both legs and current treatments haven't worked well enough.
This trial tests an experimental pain drug called suzetrigine for people with diabetic peripheral neuropathy (nerve damage from diabetes that causes pain in the feet and legs). It aims to see if the drug can safely reduce pain over time.
This study tests a new drug (HL-1186) for diabetic nerve pain. It aims to see if it reduces pain safely in people with type 1 or type 2 diabetes who have had nerve pain for at least 6 months.
Hear when a new Diabetic Peripheral Neuropathic Pain (DPN) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.